Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix

Cell

Volumn 114, Issue 1, 2003, Pages 33-45

  Hotary, Kevin B ^a   Allen, Edward D ^a   Brooks, Peter C ^c   Datta, Nabanita S ^b   Long, Michael W ^b   Weiss, Stephen J ^a  

^a UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; MATRIX METALLOPROTEINASE 14; PROTEINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CELL SHAPE; CELL SUSPENSION; CONTROLLED STUDY; CYTOSKELETON; EXTRACELLULAR MATRIX; GEL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; TUMOR CELL; TUMOR GROWTH;

ANIMALIA;

EID: 0038784546     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(03)00513-0     Document Type: Article

References (37)

1. Bernards R., Weinberg R.A. A progression puzzle. Nature. 418:2002;823.
2. Brand K., Baker A.H., Perez-Canto A., Possling A., Sacharjat M., Geheeb M., Arnold W. Treatment of colorectal liver metastases by adenoviral transfer of tissue inhibitor of metalloproteinases-2 into the liver tissue. Cancer Res. 60:2000;5723-5730.
3. Brinckerhoff C.E., Matrisian L.M. Matrix metalloproteinases. a tail of a frog that became a prince Nat. Rev. Mol. Cell. Biol. 3:2002;207-214.
4. Chambers A.F., Groom A.C., MacDonald I.C. Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer. 2:2002;563-572.
5. Chen C.S., Mrksich M., Hunag S., Whitesides G.M., Ingber D.E. Geometric control of cell life and death. Science. 276:1997;1425-1428.
6. Coussens L.M., Fingleton B., Matrisian L.M. Matrix metalloproteinase inhibitors and cancer. trials and tribulations Science. 295:2002;2387-2392.
7. Cukierman E., Pankov R., Stevens D.R., Yamada K.M. Taking cell-matrix adhesions to the third dimension. Science. 294:2001;1708-1712.
8. Cukierman E., Pankov R., Yamada K.M. Cell interactions with three-dimensional matrices. Curr. Opin. Cell Biol. 14:2002;633-639.
9. Datta N.S., Williams J.L., Long M.W. Novel alterations in CDK1/cyclin B kinase complex formation occur during the acquisition of a polyploidy DNA content. Mol. Biol. Cell. 7:1996;209-223.
10. Deryugina E.I., Soroceanu L., Strongin A.Y. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis. Cancer Res. 62:2002;580-588.
11. Eckes B., Zigrino P., Kessler D., Holtkotter O., Shephard P., Mauch C., Krieg T. Fibroblast-matrix interactions in wound healing and fibrosis. Matrix Biol. 19:2000;325-332.
12. Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer. 2:2002;161-174.
13. 3 mRNA by fibrin J. Invest. Dermatol. 113:1999;913-919.
14. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 100:2000;57-70.
15. Hay E.D. Cell Biology of Extracellular Matrix. 1991;Plenum Press, New York.
16. kip1. Proc. Natl. Acad. Sci. USA. 97:2000;10026-10031.
17. Hidalgo M., Eckhardt S.G. Development of matrix metalloproteinase inhibitors in cancer therapy. J. Natl. Cancer Inst. 93:2001;178-193.
18. Hiraoka N., Allen E., Apel I.J., Gyetko M.R., Weiss S.J. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell. 95:1998;365-377.
19. Hotary K., Allen E., Punturieri A., Yana I., Weiss S.J. Regulation of cell invasion and morphogenesis in a 3-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2 and 3. J. Cell Biol. 149:2000;1309-1323.
20. Hotary K.B., Yana I., Sabeh F., Li X.-Y., Holmbeck K., Birkedal-Hansen H., Allen E.D., Hiraoka N., Weiss S.J. Matrix metalloproteinases regulate fibrin-invasive activity via MT1-MMP-dependent and independent processes. J. Exp. Med. 195:2002;295-308.
21. Ingber D.E. Mechanosensation through integrins. cells act locally but think globally Proc. Natl. Acad. Sci. USA. 100:2003;1472-1474.
22. Koyama H., Raines E.W., Bornfeld K.E., Roberts J.M., Ross R. Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of cdk2 inhibitors. Cell. 87:1996;1069-1078.
23. Liotta L.A., Kohn E.C. The microenvironment of the tumour-host interface. Nature. 411:2001;375-379.
24. Liu X., Wu H., Byrne M., Jeffrey J., Krane S., Jaenisch R. A targeted mutation at the known collagenase cleavage site in mouse type I collagen impairs tissue remodeling. J. Cell Biol. 130:1995;227-237.
25. Montgomery A.M.P., Mueller B.M., Reisfeld R.A., Taylor S.M., DeClerck Y.A. Effect of tissue inhibitor of the matrix metalloproteinases-2 expression on the growth and spontaneous metastasis of a human melanoma cell line. Cancer Res. 54:1994;5467-5473.
26. Nishiyama T., Tsunenaga M., Nakayama Y., Adachi E., Hayashi T. Growth rate of human fibroblasts is repressed by the culture within reconstituted collagen matrix but not by the culture on the matrix. Matrix. 9:1989;193-199.
27. Ohuchi E., Imai K., Fujii Y., Sato H., Seiki M., Okada Y. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J. Biol. Chem. 272:1997;2446-2451.
28. Pei D., Weiss S.J. Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature. 375:1995;244-247.
29. Petitclerc E., Stromblad S., von Schalscha T.L., Mitjans F., Piulats J., Montgomery A.M.P., Cheresh D.A., Brooks P.C. Integrin αvβ3 promotes M21 melanoma growth in human skin by regulating tumor cell survival. Cancer Res. 59:1999;2724-2730.
30. Seiki M. The cell surface. the stage for matrix metalloproteinase regulation of migration Curr. Opin. Cell Biol. 14:2002;624-632.
31. Sounni N.E., Devy L., Hajitou A., Frankenne F., Munaut C., Gilles C., Deroanne C., Thompson E.W., Foidart J.M., Noel A. MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression. FASEB J. 16:2002;555-564.
32. Takahashi M., Tsunoda T., Seiki M., Nakamura Y., Furukawa Y. Identification of membrane-type matrix metalloproteinase-1 as a target of the β-catenin/Tcf4 complex in human colorectal cancers. Oncogene. 21:2002;5861-5867.
33. Tan J.L., Tien J., Pirone D.M., Gray D.S., Bhadriraju K., Chen C.S. Cells lying on a bed of microneedles. an approach to isolate mechanical force Proc. Natl. Acad. Sci. USA. 100:2003;1484-1489.
34. Walpita D., Hay E. Studying actin-dependent processes in tissue culture. Nat. Rev. Mol. Cell. Biol. 3:2002;137-141.
35. 5 contribute to cell attachment to vitronectin but differentially distribute on the cell surface. J. Cell Biol. 113:1991;919-929.
36. Xu J., Rodriguez D., Petitclerc E., Kim J.J., Hangai M., Yuen S.M., Davis G.E., Brooks P.C. Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo. J. Cell Biol. 154:2001;1069-1079.
37. Yana I., Weiss S.J. Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases. Mol. Biol. Cell. 11:2000;2387-2401.